Assert-IQ vs cV5 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

cV5 Diagnostic Ultrasound System

by Samsung Medison Co.

AI Verdict

Assert-IQ is an insertable cardiac monitor designed for long-term, continuous arrhythmia detection through electrical monitoring, leveraging AI for advanced analysis. In contrast, the cV5 Diagnostic Ultrasound System is an AI-assisted ultrasound machine that provides high-quality imaging for real-time structural and functional diagnosis across various medical specialties, including cardiology. While both tools utilize AI within cardiology, they serve distinct diagnostic purposes with fundamentally different technologies and approaches.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous monitoring for suspected intermittent heart rhythm disorders that may not be captured by shorter-term diagnostic tests. This system is ideal for patients requiring extended surveillance (up to 6 years) to detect and manage complex arrhythmias remotely, providing proactive alerts and patient-activated symptom logging.

View Assert-IQ →

Choose cV5 Diagnostic Ultrasound System if…

Choose the cV5 Diagnostic Ultrasound System if your clinical practice requires versatile, high-quality real-time imaging across multiple specialties like cardiology, OB/GYN, or radiology. This system is best suited for immediate diagnostic decision-making, leveraging AI-assisted tools and a broad range of transducers for detailed anatomical and functional visualization.

View cV5 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	cV5 Diagnostic Ultrasound System
Pricing	Unknown	Contact for pricing
Deployment	Subcutaneously implanted device with mobile app connectivity	On-premise hardware
FDA Status	Cleared AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV5 Diagnostic Ultrasound System

Tool B emphasizes an ergonomic design, large tilting touchscreens, and a suite of AI-powered productivity tools like EzExam+u2122 and QuickScanu2122 to streamline clinician workflows and enhance direct interaction with the diagnostic equipment. While Tool A offers patient-centric usability with its minimally invasive insertion and patient activator, Tool B's features are more directly focused on improving the clinician's experience and efficiency during diagnostic procedures.

Clinical Value

cV5 Diagnostic Ultrasound System

Tool B provides high-quality imaging and extensive 'AI & Productivity Tools' such as HeartAssistu2122, AutoEF, and ArterialAnalysisu2122 for quantitative measurements across various medical specialties, leading to confident decision-making. While Tool A offers crucial long-term cardiac monitoring with advanced arrhythmia detection, Tool B's comprehensive imaging and AI analysis capabilities offer broader and deeper diagnostic impact across a wider range of clinical scenarios.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor for institutional or specific pricing information. Neither offers a free trial, making it impossible to compare their value proposition without further details on cost and potential return on investment.

Enterprise Readiness

Assert-IQ

Tool A explicitly targets 'Large health systems, hospitals, cardiology clinics' and offers a hybrid deployment with a 'secure cloud-based data platform' and 'remote monitoring capabilities,' which are highly beneficial for scalability and distributed access in large enterprises. While Tool B provides robust on-premise hardware with strong cybersecurity and integration features, Tool A's cloud-enabled approach offers a slight edge in modern enterprise scalability and flexibility.

Innovation

cV5 Diagnostic Ultrasound System

Tool B showcases a broader and more extensive array of innovative features, including its 'Crystal Architectureu2122' for superior image quality and a comprehensive suite of 'AI & Productivity Tools' like HeartAssistu2122 and ArterialAnalysisu2122. This relentless integration of advanced AI for image enhancement and workflow optimization across diverse specialties positions Tool B as more innovative in its domain compared to Tool A's focused advancements in long-term cardiac monitoring.

Support & Docs

Tie

Both tools are offered by globally recognized and established companies (Abbott Medical and Samsung Medison), which inherently suggests a strong underlying support infrastructure. However, the provided facts and web search do not offer specific details regarding documentation, training, or explicit support channels that would clearly differentiate one product over the other.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	cV5 Diagnostic Ultrasound System
Name	Assert-IQ	cV5 Diagnostic Ultrasound System
Company	Abbott Medical	Samsung Medison Co.
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	The Samsung cV5 Diagnostic Ultrasound System is a versatile, AI-assisted ultrasound solution offering high-quality imaging, streamlined workflows, and ergonomic design for confident decision-making across various medical specialties.
Data Export	yes	AVI, MPEG, JPEG, TIFF, BMP, and DICOM formats
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	Crystal Architectureu2122 with ClearVision, S-Harmonicu2122, HQ-Visionu2122, ShadowHDRu2122, MultiVision for enhanced image quality; AI & Productivity Tools: HeartAssistu2122, AutoEF, Strain+, TMAD, AutoIMT+, ArterialAnalysisu2122, EzExam+u2122, EzCompareu2122, EzPrepu2122, SonoSyncu2122, QuickScanu2122, BiometryAssistu2122; Broad compatibility with S-Vueu2122 transducers (1u201322 MHz) for diverse applications; 21.5u201d or 23.8u201d Full HD LED monitor with IPS technology and 14u201d tilting touchscreen; Multiple imaging modes: 2D, M-Mode, Color/Power Doppler, PW/CW Doppler, Tissue Doppler Imaging (TDI), Tissue Doppler Wave (TDW), 3D/4D; 512GB SSD + 1TB expanded storage for extensive data management; Data export capabilities including AVI, MPEG, JPEG, TIFF, BMP, and DICOM formats; Cybersecurity Suite with DICOM TLS and HL7 integration for secure data handling

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and cV5 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary diagnostic function and application of Assert-IQ compared to the cV5 Diagnostic Ultrasound System?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage suspected heart rhythm disorders. In contrast, the cV5 Diagnostic Ultrasound System is a versatile, AI-assisted ultrasound solution offering high-quality imaging for confident decision-making across various medical specialties, providing real-time diagnostic images.

How do the AI capabilities of each tool differ in supporting clinical decision-making?

Assert-IQ utilizes advanced AI algorithms specifically for arrhythmia detection, aiming to reduce false positives and data burden for clinicians in continuous cardiac monitoring. The cV5 system incorporates AI & Productivity Tools such as HeartAssistu2122 and AutoEF to enhance image quality, streamline ultrasound workflows, and assist with measurements across various imaging applications.

Which medical specialties are primarily served by each tool?

Assert-IQ is primarily designed for Cardiology and Internal Medicine, focusing on patients with suspected heart rhythm disorders. The cV5 Diagnostic Ultrasound System serves a broader range of specialties including Cardiology, Obstetrics & Gynecology, and Radiology, offering versatile diagnostic imaging.

What is the typical duration or scope of patient monitoring or diagnostic use for each device?

Assert-IQ provides long-term continuous cardiac monitoring for an extended period, with options for up to 6 years of monitoring. The cV5 Diagnostic Ultrasound System is used for real-time, point-in-time diagnostic imaging, offering immediate visual assessments across various applications.

How do these tools handle data export and integration with existing systems?

Assert-IQ offers data export and transmits data via Bluetoothu00ae Low Energy to a secure cloud-based platform for clinician review. The cV5 system provides extensive data export options, including AVI, MPEG, JPEG, TIFF, BMP, and DICOM formats, and features a Cybersecurity Suite with DICOM TLS and HL7 integration for secure data handling.